Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1200 of 1463 entries
View as:

Efficacy and Safety of Zuberitamab Combined with Bendamustine, Followed by Monotherapy Maintenance, in Treatment-naïve Follicular Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT06757894 Org: User:
Start: 02/01/25 End: 02/01/34 Due: 02/01/35

2 Courses of Concurrent Cisplatin Chemoradiotherapy After Surgery for High-risk Head and Neck Squamous Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06492460 Org: User:
Start: 09/20/24 End: 07/17/33 Due: 07/17/34

TACE Plus PD-1 Antibody vs TACE Alone for Unresectable HCC

Phase: N/A Priority: Normal
NCT ID: NCT03782831 Org: User:
Start: 12/11/18 End: 06/01/20 Due: 06/01/21

Nivolumab Combined With Chemoradiotherapy Sparing Concurrent Cisplatin in Nasopharyngeal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03984357 Org: User:
Start: 03/16/20 End: 03/30/26 Due: 03/30/27

JS001 Combined With TP as First-line Treatment for Unresectable or Advanced Small Cell Esophageal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT05173246 Org: User:
Start: 11/17/20 End: 11/17/25 Due: 11/17/26

Indocyanine Clearance Rate and Septic Liver Injury

Phase: N/A Priority: Normal
NCT ID: NCT01447836 Org: User:
Start: 07/31/11 End: 11/30/12 Due: 11/30/13

Transarterial Infusion of PD-1 Antibody Plus TACE-HAIC for Unresectable HCC: a Single-arm, Phase 2 Clinical Trial

Phase: N/A Priority: Normal
NCT ID: NCT04814030 Org: User:
Start: 04/20/21 End: 12/30/22 Due: 12/30/23

PD-1 Antibody for The Prevention of Adenomatous Polyps and Second Primary Tumors in Lynch Syndrome Patients

Phase: N/A Priority: Normal
NCT ID: NCT04711434 Org: User:
Start: 11/01/20 End: 12/31/25 Due: 12/31/26

The Effect of HPV Vaccine on Menstrual Cycle in Women of Reproductive Age

Phase: N/A Priority: Normal
NCT ID: NCT05838157 Org: User:
Start: 05/04/23 End: 12/31/24 Due: 12/31/25

EGFR Antibody Combined With PD-1 Inhibitor and Chemotherapy in R/M Nasopharyngeal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06802835 Org: User:
Start: 05/31/25 End: 02/20/29 Due: 02/20/30

Ablation Combined With PD-1 in HCC: Phase II Study

Phase: N/A Priority: Normal
NCT ID: NCT04652440 Org: User:
Start: 12/15/20 End: 06/30/24 Due: 06/30/25

Osimertinib as First-line Therapy for Patients With Late-stage Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03460275 Org: User:
Start: 02/26/18 End: 12/31/20 Due: 12/31/21

The Relationship Between the Flow of Arteriovenous Fistula and Cardiac Function in Haemodialysis Patients

Phase: N/A Priority: Normal
NCT ID: NCT02747966 Org: User:
Start: 04/30/09 End: 04/30/12 Due: 04/30/13

China Q Cohort Study

Phase: N/A Priority: Normal
NCT ID: NCT04197674 Org: User:
Start: 01/21/20 End: 12/31/21 Due: 12/31/22

The Efficacy and Safety of Entecavir Treatment of Patients With Acute on Chronic Hepatitis B Liver Failure

Phase: N/A Priority: Normal
NCT ID: NCT01254994 Org: User:
Start: 08/31/07 End: 12/31/10 Due: 12/31/11

HIV Results Exchange Mechanism on Promoting HIV Testing Among MSM

Phase: N/A Priority: Normal
NCT ID: NCT03984136 Org: User:
Start: 09/27/19 End: 12/31/22 Due: 12/31/23

Effect of Sulodexide on Albuminuria in Chinese Type 2 Diabetic Patients

Phase: N/A Priority: Normal
NCT ID: NCT01316068 Org: User:
Start: 03/31/11 End: 08/31/12 Due: 08/31/13

Safety & Efficacy of Peg-ASP-based CCRT in Early Stage ENKTL

Phase: N/A Priority: Normal
NCT ID: NCT06406556 Org: User:
Start: 03/01/16 End: 03/01/26 Due: 03/01/27

Surufatinib and Sintilimab in Combination With Capecitabine for Metastatic Adenocarcinoma of Small Intestine or Appendix Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT05472948 Org: User:
Start: 02/01/23 End: 11/30/25 Due: 11/30/26

Effect of Remote Ischemia Preconditioning on Myocardial Injury in Patients Undergoing Heart Valve Surgery

Phase: N/A Priority: Normal
NCT ID: NCT01175681 Org: User:
Start: 12/31/07 End: 06/30/11 Due: 06/30/12

The Efficacy and Safety of Retreatment With TAI for Patients Who Showed TACE-resistant: a Randomized Controlled Trial

Phase: N/A Priority: Normal
NCT ID: NCT02220088 Org: User:
Start: 12/31/14 End: 07/31/18 Due: 07/31/19

Real World Study of Immune Checkpoint Inhibitors for Advanced Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04086888 Org: User:
Start: 12/12/16 End: 06/20/20 Due: 06/20/21

The Effects of Dietary Supplement of Coenzyme Q10（CoQ10） on Dyslipidemia

Phase: N/A Priority: Normal
NCT ID: NCT02407548 Org: User:
Start: 07/31/15 End: 04/30/17 Due: 04/30/18

Clinical Trial of Uterine Artery Embolization for Uterine Leiomyoma

Phase: N/A Priority: Normal
NCT ID: NCT00821275 Org: User:
Start: 01/31/08 End: 12/31/18 Due: 12/31/19

The Application of Lidocaine Cream on Oral Secretions of LMA Removal During the Recovery Period in Ophthalmic Surgical Patients Under General Anesthesia

Phase: N/A Priority: Normal
NCT ID: NCT06967064 Org: User:
Start: 05/15/25 End: 05/22/25 Due: 05/22/26